Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityNon-Current DebtOther Non-Current LiabilitiesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Goldenwell Biotech (GWLL) Current Leases (2021 - 2022)

Goldenwell Biotech (GWLL) has disclosed Current Leases for 2 consecutive years, with $25372.0 as the latest value for Q4 2022.

  • For the quarter ending Q4 2022, Current Leases fell 46.9% year-over-year to $25372.0, compared with a TTM value of $25372.0 through Dec 2022, down 46.9%, and an annual FY2022 reading of $25372.0, down 46.9% over the prior year.
  • Current Leases was $25372.0 for Q4 2022 at Goldenwell Biotech, down from $29126.0 in the prior quarter.
  • Across five years, Current Leases topped out at $47779.0 in Q4 2021 and bottomed at $17069.0 in Q1 2021.